Imexhs Ltd · ASX:IME
Imexhs — Q4 2023 Earnings Presentation
13 slides from Imexhs's earnings presentation, Jan 30, 2024
Slide 1: Q4 FY23 Results
Q4 FY23 Results 30 January 2024
Slide 2: Agenda
Agenda Q4 FY23 Results 1. Business Highlights 2. Operational Highlights 3. Financial Highlights 4. New Value Proposition 5. Product and Software Updates 6. FY24 Focus 2
Slide 3: One Company with two businesses aimed at democratising access to medical expertise
One Company with two businesses aimed at democratising access to medical expertise Medical Imaging Software Radiology Services Provider of innovative, cloud-based, Outsourcing of imaging facilities AI medical imaging software and teleradiology to hospitals and solutions medical facilities 3
Slide 4: Business Highlights
Business Highlights • The Company has demonstrated the scalability of the business across different geographies with an attractive product and disruptive business model and now is focused in generating positive earnings and cashflow. • Focus is on sales within Latin America and those product develop
Slide 5: Q4 FY23 Operational Highlights
Q4 FY23 Operational Highlights • Software installation completed for • Good progress in software the 11 Hospitals of Organizacion development including General del Norte (AVIDANTI Group) advances in architecture to • Signed a 2-year radiology services reduce cloud service costs, contract with Colomb
Slide 6: Q4 FY23 Financial Highlights
Q4 FY231 Financial Highlights Sales Revenue Annual Recurring Underlying Revenue (ARR) EBITDA2 Up 48% yoy $5.7m Up 27% yoy $25.0m Break-even in Q4 $0.4m Up 22% on a constant Up 1% on a constant YTD currency basis3 currency basis 2H Revenue Closing cash Debt Up 23% vs 1H FY23 $10.9m vs $1.9m at 31 $2.
Slide 7: Summary Q4 FY23 Cash Flow
Summary Q4 FY231 Cash Flow $'000 Q4 FY23 Q4 FY22 • Closing cash balance of $2.4m as at 31-Dec-23. Net cash from (used in) operating activities 1,420 (96) • Net cash from operating activities of $1.4m; Net cash used in investing activities (343) (288) cash receipts of $7.2m in Q4. Net cash from (used
Slide 8: Progress in ARR
Progress in ARR ARR as at 31 December 2023 • $25.0m, up 27% vs pcp; up 1% on a constant currency basis ➢ Radiology services - $14.5m, up 38% vs pcp ($10.5m at 31 Dec-22) and ➢ Software - $10.5m, up 14% vs pcp ($9.2m at 31 Dec-22). Constant currency basis assumes that historic results at each year en
Slide 9: New Value Proposition
New Value Proposition Radiologists with Superpowers 1 Product. “The most advanced, contemporary and secure radiology AI enhanced software solution.” 2 Customer Service & Support. “Unparalleled customer support, setting a new industry standard.” 3 Implementation, Training & Updates. “The most efficie
Slide 10: Product and Software Updates
Product and Software Updates ● Universal Viewer v6.2 Enhancements ● Radiology Information System ➢ Hanging protocols customisation tool ➢ Achieved significant milestone - successfully feature, to improve radiologists’ experience. formulated a novel architecture, technology ➢ Integration and configur
Slide 11: Focus for FY24
Focus for FY24 Software Radiology Services 1) Rolling out New Value Proposition 1) Margin expansion • Enhanced digital security 2) Focus and growth in Ideal Client • Service levels • Integrated AI Profile • Unique tools for Radiologist 3) Tighten working capital ➢ Targeted towards Enterprise level I
Slide 12: Disclaimer
Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and co
Slide 13: Q4 FY23 Results
Q4 FY23 Results 30 January 2024